Evolus, Inc.
Status: Publicly traded
Direct answer
Evolus, Inc. is publicly traded on NASDAQ under the ticker EOLS.
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines....
Can you invest in Evolus, Inc.?
Yes. Evolus, Inc. is publicly traded on NASDAQ under the ticker EOLS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Evolus, Inc.
Detailed equity research is provided by MarketSnap.